JP2010540660A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540660A5
JP2010540660A5 JP2010528167A JP2010528167A JP2010540660A5 JP 2010540660 A5 JP2010540660 A5 JP 2010540660A5 JP 2010528167 A JP2010528167 A JP 2010528167A JP 2010528167 A JP2010528167 A JP 2010528167A JP 2010540660 A5 JP2010540660 A5 JP 2010540660A5
Authority
JP
Japan
Prior art keywords
antibody
mammal
composition
administration
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010528167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540660A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/078769 external-priority patent/WO2009046313A2/en
Publication of JP2010540660A publication Critical patent/JP2010540660A/ja
Publication of JP2010540660A5 publication Critical patent/JP2010540660A5/ja
Pending legal-status Critical Current

Links

JP2010528167A 2007-10-05 2008-10-03 哺乳類内の赤血球生成を刺激する新規の組成物および方法 Pending JP2010540660A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99781807P 2007-10-05 2007-10-05
PCT/US2008/078769 WO2009046313A2 (en) 2007-10-05 2008-10-03 Novel compositions and methods for stimulating erythropoiesis in a mammal

Publications (2)

Publication Number Publication Date
JP2010540660A JP2010540660A (ja) 2010-12-24
JP2010540660A5 true JP2010540660A5 (enExample) 2011-11-17

Family

ID=40526962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528167A Pending JP2010540660A (ja) 2007-10-05 2008-10-03 哺乳類内の赤血球生成を刺激する新規の組成物および方法

Country Status (5)

Country Link
US (1) US20100203047A1 (enExample)
EP (1) EP2195344A4 (enExample)
JP (1) JP2010540660A (enExample)
CA (1) CA2701608A1 (enExample)
WO (1) WO2009046313A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9057731B2 (en) * 2010-06-23 2015-06-16 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
SG10201912150TA (en) * 2015-10-06 2020-02-27 Alector Llc Anti-trem2 antibodies and methods of use thereof
MD3601358T2 (ro) 2017-08-03 2023-10-31 Alector Llc Anticorpi anti-TREM2 și metode de utilizare a acestora

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5767078A (en) * 1995-06-07 1998-06-16 Johnson; Dana L. Agonist peptide dimers
US6291207B1 (en) * 1995-07-28 2001-09-18 Northwestern University Herpes virus entry receptor protein
WO1998051346A1 (en) * 1997-05-12 1998-11-19 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (tr2) antibodies
WO2000061637A1 (en) * 1999-04-14 2000-10-19 Smithkline Beecham Corporation Erythropoietin receptor antibodies
US7087224B2 (en) * 2000-10-31 2006-08-08 Amgen Inc. Method of treating anemia by administering IL-1ra
EP1336619A3 (en) * 2002-02-19 2003-12-10 Millenium Pharmaceuticals, Inc. Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
CA2482938A1 (en) * 2002-04-12 2003-10-23 Human Genome Sciences, Inc. Antibodies that specifically bind to tr2
WO2007001459A2 (en) * 2004-11-15 2007-01-04 Washington University Compositions and methods for modulating lymphocyte activity
JP2006512391A (ja) * 2002-12-30 2006-04-13 スリーエム イノベイティブ プロパティズ カンパニー 組み合わせ免疫賦活薬
BRPI0419117A (pt) * 2004-11-12 2007-12-11 Genentech Inc ácido nucléico isolado, vetor, célula hospedeira, processo para produção, polipeptìdeo isolado, molécula quimérica, anticorpo, anticorpo isolado, composição de interesse, artigo de fabricação, método de alìvio de uma disfunção imune relacionada, método para determinar a presença de um polipeptìdeo em uma amostra suspeita de conter dito polipeptìdeo, método de diagnóstico de uma doença imune relacionada em um mamìfero, método de alìvio de linfoma em um mamìfero em necessidade deste, método de alìvio de doença inflamatória de intestino em um mamìfero em necessidade deste e método de alìvio de rejeição de células transplantadas em um mamìfero
US20080124340A1 (en) * 2006-04-14 2008-05-29 Borges Luis G Erythropoietin receptor agonists
WO2008146101A1 (en) * 2007-06-01 2008-12-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Ligands of hvem for treating hematologic malignancies and autoimmune diseases

Similar Documents

Publication Publication Date Title
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
CN111630070A (zh) 三特异性蛋白质及使用方法
US20140212423A1 (en) Blood-brain barrier penetrating dual specific binding proteins
RU2012107286A (ru) Высокоаффинные человеческие антитела к человеческому ангиопоэтину-2
JP2020522513A5 (enExample)
JP2018535948A5 (enExample)
JP2010526028A5 (enExample)
TW202210507A (zh) 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
TWI612059B (zh) 泛－ＥＬＲ<sup>＋</sup>ＣＸＣ趨化因子抗體
JP2014527814A5 (enExample)
CN104159920A (zh) 针对il-13和/或il-17的双重可变结构域免疫球蛋白
JP7459058B2 (ja) Ｃｄ１３７／ｈｅｒ２二重特異性物質とｐｄ－１系阻害物質とを含む併用療法およびその使用法
JP2014502955A5 (enExample)
JP2019510739A5 (enExample)
CN105324396A (zh) 针对IL-1β和/或IL-17的双重特异性结合蛋白
US20220017617A1 (en) Efficiently expressed egfr and pd-l1 bispecific binding proteins
JP2020502219A5 (enExample)
WO2018067819A1 (en) Compositions and methods for treatment of cancers
JP6933724B2 (ja) Ｎｋ細胞活性化融合タンパク質、ｎｋ細胞およびそれらを含む医薬組成物
JP2018512402A5 (enExample)
CN109152814A (zh) 方法、方案、组合和拮抗剂
HRP20161096T1 (hr) Antigenski vežući proteini specifični za komponentu p serumskog amiloida
JP2010540660A5 (enExample)
JP2020502218A5 (enExample)
JP2019503987A (ja) 改良されたｐ２ｘ７受容体結合剤およびこれを含むポリペプチド